Related Experiment Videos
Chronic progressive osteoblastic osteomyelitis: a new approach to treatment
C Törholm1, S A Hedström, K Herrlin
1Department of Infectious Diseases, University Hospital, Lund, Sweden.
Journal of Pediatric Orthopedics
|May 1, 1988
Summary
This study presents findings on chronic progressive osteoblastic osteomyelitis in children. Combined treatment reduced osteoblastic activity and pain in most patients, indicating effective management for this bone infection.
Area of Science:
- Orthopedics
- Infectious Diseases
- Pediatric Bone Disorders
Background:
- Osteoblastic osteomyelitis is a rare bone infection characterized by increased osteoblast activity.
- Nonfistulating chronic progressive forms originating in childhood present unique diagnostic and therapeutic challenges.
- Severe pain during rest or weight-bearing is a hallmark symptom.
Observation:
- The study reviewed 16 cases in 15 pediatric patients with nonfistulating chronic progressive osteoblastic osteomyelitis of long tubular bones.
- Histological examination revealed increased active osteoblasts in all cases.
- Low-virulence bacteria were identified in approximately 25% of the patients.
Findings:
- A combined treatment approach involving nonsteroidal anti-inflammatory drugs, surgical intervention, and antibiotics was implemented to reduce osteoblastic activity.
- At an average follow-up of 47 months, 11 patients achieved complete pain relief.
- Three patients experienced reduced pain, while one patient showed no improvement.
Implications:
- This multimodal treatment strategy demonstrates significant efficacy in managing pain and reducing osteoblastic activity in pediatric osteoblastic osteomyelitis.
- Early diagnosis and combined therapeutic interventions are crucial for favorable outcomes in this challenging condition.
- Further research into the specific role of low-virulence bacteria and tailored antibiotic regimens may optimize treatment protocols.